Endocrinology, Vol 122, 1860-1868, Copyright © 1988 by Endocrine Society

ARTICLES

The effects and interactions of substrates, inhibitors, and the cellular thiol-disulfide balance on the regulation of type II iodothyronine 5'-deiodinase

DL St. Germain
Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire.

Thyroid hormones rapidly inhibit type II iodothyronine 5'-deiodinase (5'DII) activity in the rat central nervous system, anterior pituitary gland, and GH3 pituitary tumor cells. To gain insight into the cellular mechanisms responsible for this down-regulation, the effects of substrates, inhibitors, and alterations in the cellular thiol-disulfide balance on 5'DII regulation were investigated. The results demonstrate that in vitro competitive inhibitors, such as iopanoic acid, as well as iodothyronine substrates induce a rapid and irreversible loss of enzyme activity in rat cerebral cortex and anterior pituitary tissue. The potency of these agents in down-regulating this enzymatic process in intact GH3 cells is directly related to their competitive inhibitory effects on 5'DII activity in vitro. Additional studies demonstrated that treatment of intact GH3 cells with the sulfhydryl-oxidizing agent diamide mimicks the effect of substrate and results in the rapid inactivation of 5'DII. In contrast, preincubation of cells with the sulfhydryl-reducing agent dithiothreitol renders the enzyme less susceptible to the down-regulatory effects of substrate. Sulfhydryl- reducing agents thus appear to play a dual role in the 5'DII process by serving as cosubstrates and by modulating the enzymes susceptibility to substrate-induced down-regulation. These findings suggest that the in vivo inhibition of 5'DII by thyroid hormones involves a unique mechanism of enzyme regulation whereby the binding of ligand to the active site induces the rapid and irreversible inactivation and/or degradation of the enzyme. This inactivation of 5'DII initiated by substrate binding may be mediated by alterations in the sulfhydryl state of the enzyme as it progresses through the catalytic cycle.

This article has been cited by other articles:

				A. Lamirand, G. Mercier, M. Ramauge, M. Pierre, and F. Courtin Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes Endocrinology, October 1, 2007; 148(10): 4745 - 4753. [Abstract] [Full Text] [PDF]

				C. Fekete, B. C. G. Freitas, A. Zeold, G. Wittmann, A. Kadar, Z. Liposits, M. A. Christoffolete, P. Singru, R. M. Lechan, A. C. Bianco, et al. Expression Patterns of WSB-1 and USP-33 Underlie Cell-Specific Posttranslational Control of Type 2 Deiodinase in the Rat Brain Endocrinology, October 1, 2007; 148(10): 4865 - 4874. [Abstract] [Full Text] [PDF]

				M. S Wagner, S. M Wajner, J. M Dora, and A. L. Maia Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient C3H mice J. Endocrinol., June 1, 2007; 193(3): 435 - 444. [Abstract] [Full Text] [PDF]

				P. Laurberg, H. Vestergaard, S. Nielsen, S. E. Christensen, T. Seefeldt, K. Helleberg, and K. M. Pedersen Sources of Circulating 3,5,3'-Triiodothyronine in Hyperthyroidism Estimated after Blocking of Type 1 and Type 2 Iodothyronine Deiodinases J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2149 - 2156. [Abstract] [Full Text] [PDF]

				A. Zeold, L. Pormuller, M. Dentice, J. W. Harney, C. Curcio-Morelli, S. M. Tente, A. C. Bianco, and B. Gereben Metabolic Instability of Type 2 Deiodinase Is Transferable To Stable Proteins Independently of Subcellular Localization J. Biol. Chem., October 20, 2006; 281(42): 31538 - 31543. [Abstract] [Full Text] [PDF]

				T. Morimura, K. Tsunekawa, T. Kasahara, K. Seki, T. Ogiwara, M. Mori, and M. Murakami Expression of Type 2 Iodothyronine Deiodinase in Human Osteoblast Is Stimulated by Thyrotropin Endocrinology, April 1, 2005; 146(4): 2077 - 2084. [Abstract] [Full Text] [PDF]

				S Van der Geyten, N Byamungu, G E Reyns, E R Kuhn, and V M Darras Iodothyronine deiodinases and the control of plasma and tissue thyroid hormone levels in hyperthyroid tilapia (Oreochromis niloticus) J. Endocrinol., March 1, 2005; 184(3): 467 - 479. [Abstract] [Full Text] [PDF]

				F. W. J. S. Wassen, W. Klootwijk, E. Kaptein, D. J. Duncker, T. J. Visser, and G. G. J. M. Kuiper Characteristics and Thyroid State-Dependent Regulation of Iodothyronine Deiodinases in Pigs Endocrinology, September 1, 2004; 145(9): 4251 - 4263. [Abstract] [Full Text] [PDF]

				G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor Endocrinology, April 1, 2002; 143(4): 1190 - 1198. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				M. Braga and D. S. Cooper Oral Cholecystographic Agents and the Thyroid J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1853 - 1860. [Abstract] [Full Text]

				B. Gereben, C. Goncalves, J. W. Harney, P. R. Larsen, and A. C. Bianco Selective Proteolysis of Human Type 2 Deiodinase: A Novel Ubiquitin-Proteasomal Mediated Mechanism for Regulation of Hormone Activation Mol. Endocrinol., November 1, 2000; 14(11): 1697 - 1708. [Abstract] [Full Text]

				J. M. Bates, Vickie. L. Spate, J. S. Morris, D. L. St. Germain, and V. A. Galton Effects of Selenium Deficiency on Tissue Selenium Content, Deiodinase Activity, and Thyroid Hormone Economy in the Rat during Development Endocrinology, July 1, 2000; 141(7): 2490 - 2500. [Abstract] [Full Text] [PDF]

				J. Steinsapir, A. C. Bianco, C. Buettner, J. Harney, and P. R. Larsen Substrate-Induced Down-Regulation of Human Type 2 Deiodinase (hD2) Is Mediated through Proteasomal Degradation and Requires Interaction with the Enzyme's Active Center Endocrinology, March 1, 2000; 141(3): 1127 - 1135. [Abstract] [Full Text] [PDF]

				S.-W. Kim, J. W. Harney, and P. R. Larsen Studies of the Hormonal Regulation of Type 2 5'-Iodothyronine Deiodinase Messenger Ribonucleic Acid in Pituitary Tumor Cells Using Semiquantitative Reverse Transcription-Polymerase Chain Reaction Endocrinology, December 1, 1998; 139(12): 4895 - 4905. [Abstract] [Full Text] [PDF]

				L. A. Burmeister, J. Pachucki, and D. L. St. Germain Thyroid Hormones Inhibit Type 2 Iodothyronine Deiodinase in the Rat Cerebral Cortex by Both Pre- and Posttranslational Mechanisms Endocrinology, December 1, 1997; 138(12): 5231 - 5237. [Abstract] [Full Text] [PDF]